Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 2/20 | 0.44 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 10/20 | 0.39 |
| ▸ | LPL | P06858 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | HTR1D | P28221 | 1/20 | 0.35 |
| ▸ | HTR1B | P28222 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6994884 | 0.80 | GAA (0.44) | PGR | |
| SCHEMBL6993120 | 0.78 | KCNH2 (0.44) | KCNH2HDAC1LPLLIPG | |
| SCHEMBL7001776 | 0.76 | ACE2 (0.35) | — | |
| Hydrochloric Acid SCHEMBL6988641 | 0.76 | ACE2 (0.34) | — | |
| SCHEMBL7001780 | 0.72 | NR3C2 (0.34) | — | |
| SCHEMBL7988325 | 0.72 | ALDH1A1 (0.36) | KCNH2 | |
| Hydrochloric Acid SCHEMBL6988645 | 0.71 | NR3C2 (0.33) | — | |
| SCHEMBL6999042 | 0.71 | ACE2 (0.47) | — | |
| SCHEMBL7710771 | 0.70 | KCNH2 (0.41) | KCNH2PGRSLC6A11HDAC1HDAC2 | |
| SCHEMBL7000241 | 0.70 | PARP1 (0.52) | KCNH2PGRSLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1015437-B1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 2003-12-03 | — | — | EP | disclosed |
| US-6365736-B1 | TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-1015437-A1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999012915-A1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-03-18 | — | — | WO | disclosed |